Bioventus Shares Rise After Analyst Upgrade

Cantor Fitzgerald boosts stock to strong buy rating, citing positive outlook

Published on Mar. 5, 2026

Got story updates? Submit your updates here. ›

Shares of Bioventus Inc. (NASDAQ:BVS), a global medical device company specializing in orthobiologic solutions, rose sharply after Cantor Fitzgerald upgraded the stock to a strong-buy rating. The stock opened at $9.00, up from the previous close of $8.47, and closed the day at $9.27 with over 295,000 shares traded.

Why it matters

The analyst upgrade is a positive sign for Bioventus, which develops and commercializes non-surgical therapies for musculoskeletal conditions. The company's flagship EXOGEN Ultrasound Bone Healing System has been widely used to stimulate bone growth, and the upgrade suggests Wall Street sees further growth potential for the company.

The details

Cantor Fitzgerald cited Bioventus' strong product portfolio and positive outlook in upgrading the stock. The company reported quarterly earnings of $0.24 per share on revenue of $157.9 million. Bioventus has a market cap of $754.8 million and a debt-to-equity ratio of 1.50.

  • Bioventus shares closed at $8.47 on the previous trading day.
  • The stock opened at $9.00 on the day of the upgrade announcement.

The players

Bioventus Inc.

A global medical device company specializing in orthobiologic solutions aimed at accelerating healing and improving patient outcomes in musculoskeletal conditions.

Cantor Fitzgerald

An investment bank and financial services firm that upgraded Bioventus to a strong-buy rating.

Got photos? Submit your photos here. ›

What they’re saying

“We must not let individuals continue to damage private property in San Francisco.”

— Robert Jenkins, San Francisco resident (San Francisco Chronicle)

The takeaway

The analyst upgrade is a positive sign for Bioventus, suggesting Wall Street sees further growth potential for the company's orthobiologic solutions, particularly its flagship EXOGEN Ultrasound Bone Healing System. The stock's sharp rise on the news indicates investor confidence in the company's future prospects.